Acasti Pharma Inc. (ACST)
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 8:00 PM
4.01% (1D)
| Bid | n/a |
| Market Cap | 34.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.03M |
| EPS (ttm) | -1.43 |
| PE Ratio (ttm) | -2.36 |
| Forward PE | -2.67 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 27,682 |
| Avg. Volume (20D) | 30,062 |
| Open | 3.43 |
| Previous Close | 3.24 |
| Day's Range | 3.20 - 3.45 |
| 52-Week Range | 1.98 - 3.60 |
| Beta | 1.52 |
About ACST
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada....
Industry Biotechnology
Sector Healthcare
IPO Date Feb 7, 2012
Employees 32
Stock Exchange NASDAQ
Ticker Symbol ACST
Website https://www.acastipharma.com
10 months ago · investorplace.com
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024As the main stock indices like the S&P 500 and Nasdaq continue to climb, penny stocks are becoming attractive for those seeking significant returns. Despite their reputation for extreme price fluctuat...
